MedPath

Effect of establishing a standardized, individually adapted pain therapy to reduce acute postoperative pain in ophthalmic surgery - a prospective observational study

Conditions
H57.1
Ocular pain
Registration Number
DRKS00030059
Lead Sponsor
niversitätsklinikum KölnKlinik für Anästhesiologie und Operative Intensivemdizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
350
Inclusion Criteria

Patients undergoing orbitotomy, enucleation of the eye, corneal transplantation or other eye surgery
Minimum age 18 years
Present, signed informed consent form
Patient consent after detailed information about the study
ASA classification I-III
50 - 120 kg body weight

Exclusion Criteria

Intolerance to ibuprofen, metamizole, tilidine, tramadol, oxycodone, or morphine
Patients under 18 years of age
Patients who have not signed a consent form
Patients who could not be adequately informed due to language and comprehension problems.
Patients who were not cleared for surgery after the premedication visit due to their pre-existing conditions released for surgery

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint of this observational study is pain severity reported on all postoperative days and at discharge.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints are quality of life, (additional) analgesic consumption, adverse events, mortality, morbidity, and perioperative complications, e.g., wound healing disorders.
© Copyright 2025. All Rights Reserved by MedPath